176 related articles for article (PubMed ID: 26866719)
1. Association of Serum Uric Acid and Disease Duration With Frequent Gout Attacks: A Case-Control Study.
Abhishek A; Valdes AM; Zhang W; Doherty M
Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1573-7. PubMed ID: 26866719
[TBL] [Abstract][Full Text] [Related]
2. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
[TBL] [Abstract][Full Text] [Related]
3. Current gout treatment and flare in South Korea: Prophylactic duration associated with fewer gout flares.
Choi HJ; Lee CH; Lee JH; Yoon BY; Kim HA; Suh CH; Choi ST; Song JS; Joo HY; Choi SJ; Lee JS; Shin KC; Baek HJ
Int J Rheum Dis; 2017 Apr; 20(4):497-503. PubMed ID: 25160939
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
[TBL] [Abstract][Full Text] [Related]
5. Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.
Hatoum H; Khanna D; Lin SJ; Akhras KS; Shiozawa A; Khanna P
Postgrad Med; 2014 Mar; 126(2):65-75. PubMed ID: 24685969
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare.
Janssen CA; Oude Voshaar MAH; Ten Klooster PM; Vonkeman HE; van de Laar MAFJ
Clin Rheumatol; 2019 Aug; 38(8):2233-2239. PubMed ID: 31030363
[TBL] [Abstract][Full Text] [Related]
7. Uricosuric medications for chronic gout.
Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
[TBL] [Abstract][Full Text] [Related]
8. Benefits of uric acid-lowering medication after bariatric surgery in patients with gout.
Song K; He M; Kong X; Xian Y; Zhang Y; Xie X; Xie S; Jia A; Ren Y
BMC Surg; 2024 Jun; 24(1):186. PubMed ID: 38877436
[TBL] [Abstract][Full Text] [Related]
9. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
Khanna P; Khanna D; Storgard C; Baumgartner S; Morlock R
Postgrad Med; 2016 Jan; 128(1):34-40. PubMed ID: 26578028
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities and factors influencing frequent gout attacks in patients with gout: a cross-sectional study.
Liang J; Jiang Y; Huang Y; Huang Y; Liu F; Zhang Y; Yang M; Wu J; Xiao M; Cao S; Gu J
Clin Rheumatol; 2021 Jul; 40(7):2873-2880. PubMed ID: 33538925
[TBL] [Abstract][Full Text] [Related]
11. Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review.
Shiozawa A; Szabo SM; Bolzani A; Cheung A; Choi HK
J Rheumatol; 2017 Mar; 44(3):388-396. PubMed ID: 28148699
[TBL] [Abstract][Full Text] [Related]
12. An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
Becker MA; Fitz-Patrick D; Choi HK; Dalbeth N; Storgard C; Cravets M; Baumgartner S
Semin Arthritis Rheum; 2015 Oct; 45(2):174-83. PubMed ID: 26190562
[TBL] [Abstract][Full Text] [Related]
13. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
[TBL] [Abstract][Full Text] [Related]
14. Serum urate levels and gout flares: analysis from managed care data.
Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and risk factors for gout attacks during anti-tuberculosis treatment: A case-control study in South Korea.
Ha YJ; Chung SW; Lee JH; Kang EH; Lee YJ; Song YW
Int J Rheum Dis; 2019 Oct; 22(10):1905-1911. PubMed ID: 31531949
[TBL] [Abstract][Full Text] [Related]
16. Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study.
Lorenzin M; Ughi N; Ariani A; Raffeiner B; Frallonardo P; Hoxha A; Ortolan A; Favero M; Parisi S; Bortoluzzi A; Ceccarelli F; Lucchetti R; Furini F; Del Ross T; Zanetti A; Carrara G; Scirè CA; Doria A; Ramonda R;
Clin Exp Rheumatol; 2023 Mar; 41(3):628-633. PubMed ID: 35930471
[TBL] [Abstract][Full Text] [Related]
17. Renal excretion is a cause of decreased serum uric acid during acute gout.
Zhao T; Lv X; Cao L; Guo M; Zheng S; Xue Y; Zou H; Wan W; Zhu X
Int J Rheum Dis; 2018 Sep; 21(9):1723-1727. PubMed ID: 30345643
[TBL] [Abstract][Full Text] [Related]
18. Adherence and persistence to urate-lowering therapies in the Irish setting.
McGowan B; Bennett K; Silke C; Whelan B
Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a urate lowering regimen in primary gout.
Bailén R; González Senac NM; López MM; Llena ML; Migoya M; Rodríguez MT; de Miguel E; Torres RJ; Puig JG
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):174-80. PubMed ID: 24940666
[TBL] [Abstract][Full Text] [Related]
20. Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank.
Sandoval-Plata G; Nakafero G; Chakravorty M; Morgan K; Abhishek A
Rheumatology (Oxford); 2021 Jul; 60(7):3243-3251. PubMed ID: 33313843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
